STATE STREET CORP - HEPION PHARMACEUTICALS INC ownership

HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 43 filers reported holding HEPION PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$243,433
+29.4%
313,500
-50.0%
0.00%
Q4 2022$188,162
+19.1%
627,000
+100.0%
0.00%
Q3 2022$158,000
-11.7%
313,5000.0%0.00%
Q2 2022$179,000
-60.2%
313,500
-10.1%
0.00%
Q1 2022$450,000
+22.3%
348,910
+8.1%
0.00%
Q4 2021$368,000
-25.5%
322,7160.0%0.00%
Q3 2021$494,000
-22.7%
322,7160.0%0.00%
Q2 2021$639,000322,7160.00%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 306,338$564,0000.11%
PVG ASSET MANAGEMENT CORP 14,140$26,018,0000.08%
GSA CAPITAL PARTNERS LLP 160,775$296,0000.05%
Virtu Financial LLC 179,030$329,0000.02%
Allen Capital Group, LLC 23,685$44,0000.01%
McAdam, LLC 36,641$67,0000.01%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 10,000$18,0000.01%
ZEKE CAPITAL ADVISORS, LLC 50,000$92,0000.01%
JGP Wealth Management, LLC 15,000$28,0000.01%
Onex Canada Asset Management Inc. 40,000$74,0000.00%
View complete list of HEPION PHARMACEUTICALS INC shareholders